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ABSTRACT
Introduction: Cerebral palsy (CP) is the most
common physical disability in childhood. It is a
disorder resulting from sensory and motor
impairments due to perinatal brain injury, with lifetime
consequences that range from poor adaptive and social
function to communication and emotional
disturbances. Infants with CP have a fundamental
disadvantage in recovering motor function: they do not
receive accurate sensory feedback from their
movements, leading to developmental disregard.
Constraint-induced movement therapy (CIMT) is one of
the few effective neurorehabilitative strategies shown to
improve upper extremity motor function in adults and
older children with CP, potentially overcoming
developmental disregard.
Methods and analysis: This study is a randomised
controlled trial of children 12–24 months corrected age
studying the effectiveness of CIMT combined with
motor and sensory-motor interventions. The study
population will comprise 72 children with CP and 144
typically developing children for a total of N=216
children. All children with CP, regardless of group
allocation will continue with their standard of care
occupational and physical therapy throughout the
study. The research material collected will be in the
form of data from high-density array event-related
potential scan, standardised assessment scores and
motion analysis scores.
Ethics and dissemination: The study protocol was
approved by the Institutional Review Board. The
findings of the trial will be disseminated through peer-
reviewed journals and scientific conferences.
Trial registration number: NCT02567630.
INTRODUCTION
Background and rationale
Cerebral palsy (CP) is the most common
physical disability in childhood.1 It affects
3.6/100 children in the USA2 with ∼10 000
new diagnoses every year.3 The prevalence of
CP in developing countries is estimated to be
∼5–10 times greater.4 CP is a disorder result-
ing from sensory and motor impairments
due to perinatal brain injury,5–8 with lifetime
consequences that range from poor adaptive
and social function to communication and
emotional disturbances,9 all contributing to a
shortened life expectancy.10–14 The societal
costs are difﬁcult to estimate but the ﬁnan-
cial burden is well over $1 M per life
affected.15–17 A growing number of evidence-
based therapies aim to improve gross motor
function through changes in body structures
and function in children with CP (eg, hip
surveillance, surgery).18 However, infants
with CP have a fundamental disadvantage in
recovering motor function: they do not
receive accurate sensory feedback from their
movements,19 20 leading to neglect of an
affected extremity and difﬁculty learning
new movements, a process called develop-
mental disregard (DD).21–23 As a conse-
quence, even children who receive
time-intensive and resource-intensive stand-
ard therapies have stable or declining motor
function and developmental trajectories that
do not ‘catch up’ to those of typically devel-
oping (TD) children.24–28 DD can then lead
to school-age learning problems, decreased
participation in physical and social activities
and costly long-term mental and physical
morbidities.29–32
Constraint-induced movement therapy
(CIMT) is one of the few effective neuroreh-
abilitative strategies shown to improve upper
extremity motor function in adults and older
children with CP,33–35 potentially overcoming
DD. It is mainly applicable to CP patients
who are diagnosed with asymmetric or hemi-
paretic forms of the disorder,36 in which one
side of the body is more affected than the
Chorna O, et al. BMJ Open 2015;5:e010212. doi:10.1136/bmjopen-2015-010212 1
Open Access Protocol
other. CIMT is based on the premise that preferential
use of an affected upper extremity (by constraining the
less affected one), and shaping with repetition of move-
ment by skilled therapists, can overcome neglect and
restore function of that extremity.22 However, published
pediatric CIMT studies have multiple limitations:
Participants are mostly older children past the period
of maximal neural plasticity in early childhood (∼3 years
of age) when interventions have the potential for great-
est impact.37 38
Developmental trajectories are rarely examined,
mostly due to the challenges of intensive, specialised
therapy and limited options for objective assessments in
very young and often in preverbal patients.
Large randomised controlled trials (RCTs) are rare in
the USA.39–43 This may be due to the difﬁculties of equi-
poise in this vulnerable population, where parents
believe that any treatment is better than none44–46 and
studies indicate beneﬁt without harm.
Therapeutic strategies focus on development of new
motor patterns and pathways and rarely account for the
importance of connectivity between sensory and motor
systems in inferring new movements.
Our protocol uses a multidisciplinary approach to
overcome these challenges and leverages the established
experience with CIMT, infant motor learning of reach,
and novel objective measures of sensory function, all
unique to our research group. We plan an RCT to test
the effectiveness of CIMT, combined with motor and
sensory-motor interventions in children aged 12–24
months, using objective, quantitative measures to assess
somatosensory, kinematics and developmental motor
function. The goal of this project is to provide both clin-
ical data on the value of CIMT in infants and mechanis-
tic data to inform improved designs of interventions for
CP in infancy.
Our intervention and assessment methodologies allow
a trial in children aged 12–24 months at intervention
start, when neural plasticity and potential downstream
beneﬁts are optimal.47 48
By combining standard motor assessments and bio-
mechanics of reach with cortical measures of sensory
function, we address mechanistic gaps in the role of
somatosensory processing in motor impairment in CP.
Our quantitative measures of the treatment’s ability to
change sensory processing and upper extremity function
will inform future CIMT design modiﬁcations.
Use of a wait-list control for comparison to the inter-
vention allows every infant with CP to eventually receive
CIMT. We study timing of CIMT only within the context
of developmental trajectories, not in the RCT, to avoid a
common problem of confounding amount of total treat-
ment with age at treatment entry.
We examine the role of CIMT on the developmental
trajectories of children with CP referenced to TD chil-
dren and the role of severity of CP in treatment response.
From a public health perspective, our use of a
low-cost, low technology version of CIMT with a proven
parent-driven training component allows adaptation of
the therapy to a socioeconomically and geographically
diverse population.
Our novel approach to therapy design for paediatric
CP addresses ‘the gaps in the continuum of translational
research and the WHO-ICF framework’ in order to
‘increase the clinical and societal relevance of rehabilita-
tion research throughout the NIH and is thus consistent
with recommendations by the Blue Ribbon Panel on
Rehabilitation Research’ (NIH, June 2012).
To accomplish the goals of our protocol and meet
the mandates of the National Center for Medical
Rehabilitation Research, our focus, methodology and
design are creative and highly novel. The only
NIH-funded trial of CIMT in infants aged 6–18 months49
tests intensive therapist-assisted training in the home
(3 h/day) and placement of a non-removable cast versus
a splint or no constraint. In addition to concerns of
immobilisation of the unaffected extremity, that project
does not study the impact of motor learning on develop-
mental trajectories and reach kinematics, and does not
address the mechanistic implications of cortical sensory
function in CP.
Study the effects of rehabilitation in children aged below
2 years: To date, the studies that have focused on this
population included a small number of participants, due
to the challenges mentioned above.39 We address the
logistical issues of enrolling very young children as we
have done before50–52 by recruiting participants in our
large neonatal intensive care unit (NICU) follow-up
programmes, where we evaluate infants systematically
from birth to 3 years. Former NICU patients constitute
>60% of all children with CP due to consequences of
prematurity or perinatal insults.53
We use novel infant-friendly methodologies to quantify
cortical sensory function. Our event-related potential
(ERP) assessment is rapid, non-invasive and provides
quantitative temporal information on neural activation
in response to a non-noxious sensory stimulus.54 This is
an important advance from prior studies using electrical
stimulation55 or lengthy neuroimaging protocols, that
are poorly tolerated by infants and toddlers or require
sedation.55–58 It also overcomes the feasibility and repro-
ducibility issues in conventional behavioural assessments
of sensory function in infants noted by specialists in the
ﬁeld.59 60 Our methodology requires neither active par-
ticipation nor directed attention. As opposed to behav-
ioural measures of sensory function requiring
communication or complex cognitive functions, we can
therefore obtain quantitative and relevant information
on the group response to treatment to help optimise
future intervention designs. Our new analysis techniques
can also assess the integrity of responses for children at
the individual level.
Focus on improving DD: While adult rehabilitation after
stroke concentrates on overcoming neglect or lack of
sensory awareness,61 62 paediatric rehabilitation needs to
address the problem in the context of a developing
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human instead of a mature one.63 64 In children, the
consequences of the original lesion are ampliﬁed21 65 66
and entire classes of behaviours never develop. Our
approach tests the immediate effectiveness of CIMT and
also examines it in the context of developmental
trajectories.
Design
We are conducting a randomised trial with wait-list
control design of CIMT in children with CP using a wait-
list control group. This design allows every child with CP
to eventually receive the treatment and avoids issues of
equipoise. The RCT portion of the study extends only
for a 7-month period, from baseline to 6 months after
the 1-month CIMT ends. For CP wait-listed controls, the
study continues for 6 months following the CMIT inter-
vention, separate from the completed RCT. We will refer-
ence data from both groups to a cohort of TD children
to determine developmental trajectories.
Rationale for our design: Because CIMT has been
proven to be beneﬁcial in adults and older children,
and does not appear to result in any lasting harm,36
parents and medical personnel believe that receiving
the intervention is better than not receiving it and thus
lack equipoise. In our studies and those of others in
the USA, consent to participate in paediatric CIMT
studies approaches 100%,39–43 with long waiting lists of
interested participants. We know from our experience
and clinic demographics, that we can expect ∼6
patients with newly diagnosed CP in the requisite age
group per 3-month period, making possible a design of
staggered enrolment of control and intervention groups
in an RCT.
Design implementation
Every 3 months, six children who meet inclusion criteria
are randomly assigned to the intervention or control
group (ﬁgure 1). All children continue routine therapy.
The six children in the intervention group also receive
the CIMT intervention for 1 month. For this group, the
daily home programme replaces their standard-of-care
home programme. All children complete baseline,
1-month and 7-month assessments. After the 7-month
assessment, the intervention group has completed the
study and resumes routine care. After the 7-month
assessment, the control group receives CIMT for
1 month and is assessed 6 months later (7 months after
the start of CIMT, as in the intervention group), com-
pleting the study.
TD children matched for gestational age, gender and
corrected age (CA) are tested at baseline or 7-month
time points—to reference changes in the CP sample to
TD-mean performance.
We have addressed problems of RCT design67 as follows:
Randomisation: To strengthen interval validity of the
design, randomisation will be carried out using
uniﬁed reproducible methods (ie, saved random
number seeds) provided by the Biostatistics core. We
will use a permuted block randomisation scheme with
random block size and stratiﬁed by age at CP diagno-
sis. Data analysts will be blinded to group assignment.
Intervention ﬁdelity: Checks on the implementation of
the home-based intervention are built into the design
(see below) and between-group differences in chil-
dren with CP are clearly delineated during the RCT
period of months 0–7, as controls will only receive
standard of care protocols as directed by their paediat-
ric occupational and physical therapists. Monitoring of
constraint wear time is built into the constraint.
Differential attrition: Some participants may not return
for all visits or complete all assessments and hence
may have missing values for response variables. Often,
such dropouts are not a random sample of the entire
cohort, and analysis of only the complete cases
would bias the results.68 69 We will obtain the speciﬁc
reason for dropout on a case-by-case basis. Indirect
information about non-random dropouts will be
obtained by using binary logistic models to predict the
Figure 1 Randomised controlled trial with wait-list control design. (CIMT, constraint-induced movement therapy).
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dropout probability using baseline variables. Impact of
dropout on our results will be compared using
assumptions that vary from missing at random to
informative missing.
Study population
Inclusion and exclusion criteria
The study population will comprise 216 children, 72
with CP and 144 with TD. We anticipate the distribution
to be 60% male and 40% female, as CP affects males
more frequently than females and represents the distri-
bution at our institution,50 70 and we will match TD chil-
dren for sex and gestational age. All races and
ethnicities will be included, with an expected skew
towards slightly more African American children than in
the general population as described in the enrolment
table. Because we will include a large proportion of
former preterm infants, we will account for GA at birth
(GA) as a marker of immaturity and for CA at assess-
ment, the age of the child from the expected date of
delivery, as a representation of maturational age. CA is
calculated by subtracting the number of weeks born
before 40 weeks of gestation from the chronological age,
therefore for term infants, CA is identical to chrono-
logical age.71
CP children (n=72): Inclusion criteria will be diagnosis
of hemiparetic or asymmetric CP as determined by pub-
lished algorithms72 and neurological examinatiom,73
with CA between 12 and 24 months. Exclusion criteria
will be CP with Gross Motor Function Classiﬁcation
Score (GMFCS)74 of 4–5, corresponding to poor or
absent mobility and neck control; receipt of Botox to
the affected extremity within 3 months of study entry; or
scores of <70 on the Bayley Scales of Infant
Development (Bayley III) cognitive composite.75
TD children (n=144): Inclusion criteria will be GA and
sex-matched compared to the CP group, with CA at
assessment matched to the CP group at baseline (72
children) and at the 7-month assessment (72 children).
Exclusion criteria will be any motor or sensory impair-
ment as deﬁned by neurological examination and/or
scaled motor scores below 8 for CA on the Bayley III
and cognitive impairment or delays as described for the
CP group.
Recruitment of participants:
Institutional Review Board (IRB) approval: This study has
been approved by the Institutional Review Board (#15–
00547). It was assigned a risk level 1—no greater than
minimal risk on the Code of Federal Regulations (CFR),
(45 CFR 46.404; 21 CFR 50.51). This study will include
one site, the Nationwide Children’s Hospital in
Columbus, Ohio USA.
Recruitment: Clinic staff and/or research coordinator will
identify prospective participants during NICU follow-up
and Pediatric Rehabilitation visits. The study coordin-
ator, the research assistant, or the principal investigator,
who directs the follow-up clinic, will obtain informed
consent.
Feasibility: The NICU follow-up clinic sees a yearly
average of 58±5 children with new diagnoses of asym-
metric CP before 24 months CA. New diagnoses in the
Pediatric Rehabilitation clinic (not referred by the
NICU clinic) average 15±3. Thus, >33 children with CP
are eligible per year.
Intervention
Rationale for speciﬁc CIMT design: CIMT is based on the
principle of forced-use of a more neglected upper
extremity, as a constraint is placed on the less affected
extremity. CIMT interventions in published studies vary
widely in the duration and intensity of therapy, but most
consider 4 weeks with 2–5 h of daily motor training as
an intense course without adverse effects on the con-
strained extremity.22 42 76 Furthermore, an RCT of a
standard daily home therapy programme without CIMT
of 4 weeks duration showed measurable effects and good
parent compliance.77
However, CP affects motor pathways in the brain and
also affects sensory pathways, which complicates the
design of CIMT. In addition to injuries to corticospinal
pathways directly controlling movement, neuroimaging
studies have also conﬁrmed that the thalamocortical
ﬁbres to the sensory cortex contribute greatly to the dys-
function observed in CP.78–81 Older children and adults
with CP have tactile processing deﬁcits in detection of
touch (also called registration or sensation)59 60 82 and
in perception of tactile stimuli, a more complex neural
process that involves interpretation of the sensory infor-
mation.83 Principles of new movement inference estab-
lished in adult populations show that sensory feedback
is essential to the development of effective move-
ment.84–86 Imaging and movement studies suggest
the same is true of children with CP,87–91 making the
sensory component of learning essential to overcoming
DD (see ﬁgure 2). Both extremities must receive sensory
input and motor experiences during constraint pro-
grammes to prevent possible negative effects on sensori-
motor cortex development during a critical phase of
brain development.92 93
Shaping of movement through guided repetition
during CIMT creates experience of successful movement
essential to inferring more efﬁcient actions. Increased
and higher quality sensory feedback during movement is
also crucial to improving the brain’s ability to infer new
movements (ﬁgure 3). Providing this type of training is
challenging in children with CP who have limited volun-
tary exposure to tactile input in their affected extrem-
ity.61 94 Furthermore, in infants and young children,
action-outcome relations are an essential component of
learning new motor skills and self-produced (instead of
passive) action is a highly speciﬁc requirement of paedi-
atric learning. For this reason, shaping of movement in
our population needs to be an active task leading to a
successful outcome. Finally, to promote optimal upper
extremity function, corticospinal tract and sensorimotor
development, a complementary emphasis on bimanual
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play in addition to constraint appears to be of most
beneﬁt.95–98
Intervention design
The CIMT intervention includes three components: (1)
placement of a removable soft constraint with wear-
monitor, (2) demonstration and prescribed home-use of a
sensory-motor kit, and (3) a reach/grasp tool (ﬁgure 4).
The intervention lasts 4 weeks, with weekly checks
during already-scheduled therapy times or other clinic
visits. The study therapist will monitor the function of
the constrained extremity, download the wear-monitor
information, monitor home treatment ﬁdelity and facili-
tate training.
Constraint: We modiﬁed an existing protocol99 to suit
our population and study focus. We consulted Dr AC
Eliasson regarding the design of a soft long mitt on the
less affected arm in the baby-CIMT trial.99 In our study,
the cast is made from a quilted oven mitt extending
from the axilla over the ﬁngers, with a wear-monitor
completely covered within a pocket at the top of the
mitt (ﬁgure 2). The top of the mitt is fastened to ﬁt by
2 Velcro closures. It is worn from infant wake time in the
morning for 6 h, or approximately lunchtime.
Importantly, during non-training time, caregivers are
encouraged to actively facilitate any actions with the
non-constrained hand to minimise infant frustration.
Motor-sensory training: As detailed in the rationale,
sensory feedback during movements is essential for
accurate inference of new movement.100 To address this
component of learning, we use a sensory kit in which
children reach for toys. The kit is used daily for 15 min
and is modiﬁed from our previous three CIMT interven-
tions performed in a clinic setting with therapists and
non-medically trained volunteers.70 101 In the clinic
setting, 150 min of total sensory kit use over 5 days
resulted in improvements of grip strength still present
6 months post-treatment. The kit includes bins with
age-appropriate toys (chosen for palmar grasp holding)
hidden in textured mixes. Parents demonstrate placing
hands in the bins and ﬁnding toys, then hold children’s
hands with theirs in the bins, and as children’s reach
develops, encourage them to reach for partially hidden
toys, then fully buried toys. Parents praise children for
placing their hands in the bins, regardless of outcome.
Reach training: Because prior experience of successful
movement is critical to achieving improved inference of
new movements, we modiﬁed training to accommodate
12–24-month-old children with CP, based on validated
infant-appropriate procedures in which the reaching
task is facilitated by using specialised mittens.102 These
‘sticky’ mittens allow infants with immature grasp (com-
parable to the poor grasp in the affected extremity of children
with CP) to successfully reach and obtain an object from
the tray pedestal (ﬁgure 5). Studies in the Needham
laboratory show that typical 3-month-old infants, who do
not have reaching abilities, trained for 10 min per day in
an active reaching task by their parents (2 h total
Figure 2 Soft mitt constraint.
Figure 3 Developmental
disregard impairs learning of new
and effective movements in
children with CP. (CIMT,
constraint-induced movement
therapy; CP, cerebral palsy).
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training over 2 weeks) have signiﬁcant improvements in
their reach and grasp behaviours relative to a control
group without the mittens. The Needham group further
demonstrated that this was due to success during active
learning of movement, as passive teaching by observing
parents did not improve reaching to the same
extent.102–105
Our CIMT intervention lasts 28 days, resulting in ∼4.5
active training-hours of the more affected extremity.
Infants receive a custom-made mitten with Velcro (loop
side) sewn to the palm, and three sets of training toys,
all made ‘sticky’ with Velcro (hooks side) on one side
only. Toys are placed on a (provided) non-movable tray
with a pedestal (Zukun Plan, LLC, Columbus Ohio,
USA) at full reaching distance on in front of the infant
sitting in a high chair. Parents then demonstrate that
toys will stick to the child’s mitten, place toys back, and
draw attention to toys. Parents may move the child’s arm
to the toy if the infant does not initiate reach, once for
each set of toys. Children then must reach out for toys
themselves and may manipulate toys before the
sequence is repeated for the next toy for a total of
10 min. To ensure good postural support during reach,
especially of infants GMFCS of III, infants will be evalu-
ated at intervention start to assess the need for a possible
trunk support strap to be added to the high chair.
Support of bimanual activities during non-constrained time:
Infants will spend approximately ½ their day in the soft
restraint and the other half with both hands free. During
this time, parents will encouraged to play with a set of pro-
vided simple toys and games shown to promote bimanual
function and adapted from older children’s RCTs.106
Monitoring of treatment fidelity
Duration: The constraint wear time will be monitored
using a Fitbit® device incorporated into the mitt. Wear
of the mitt activates the Fitbit because the constrained
arm still moves either in involuntary small movements or
as an assist. When the mitt was on for training and daily
living activities, the Fitbit recorded the times as ‘awake’
or ‘restless’ with 100% accuracy for wear time at the
minute level.
Frequency of training: Parents will record how many
10 min reaching and 15 min sensory exposure sessions
they conducted in a daily paper or electronic log.
Alternatively, parents will have the option of document-
ing task completion through SMS responses to the coor-
dinator’s phone, a model currently used to respond to
scheduled appointments at our institution. Families will
also be provided with support systems, including a ther-
apist (pager and email contact) and a website where
they can watch a video of the training.
Quality of training: At the weekly checkpoints, the study
therapist will observe parents demonstrate both training
tasks in their entirety with the child. During this observa-
tion, the therapist will record duration of training, parent
implementation of task and parent support of child,
using a checklist to compare to the initial demonstration.
The effectiveness of the protective and educational
support measures will be assessed on a weekly basis
during the intervention and at every assessment time
point by the study therapists. Any and all adverse events
will immediately be documented and the IRB will be
notiﬁed according to approved protocols. Participants
can withdraw from the study at any time by notifying the
Figure 5 Infant reaching using affected hand with purple
sticky mitten (Velcro on palm) for and object with Velcro (pink
pig, white Velcro).
Figure 4 Intervention flow diagram. (OT, Occupational
therapy; PT, Physical therapy).
6 Chorna O, et al. BMJ Open 2015;5:e010212. doi:10.1136/bmjopen-2015-010212
Open Access
study coordinator. In the event of adverse effects requir-
ing medical or professional intervention the participants will
immediately be cared for by the paediatric providers at
our facility at no cost to them.
The hypothetical risks of placing a constraint for 6 h
each day on the less affected extremity will be addressed
as follows: prior to encouraging the continued wear of
the long mitt each week, both the more and the less
affected extremity will be tested for grip and pinch using
dynamometers and ﬁve repeated assessments in each
hand. These measures test strength and integration of
motor and sensory feedback pathways.
If pinch or grip strength have decreased (>1 SD on
ﬁve repeated measurements compared to baseline), the
treatment will be stopped and the child will receive
intensive bimanual strength and sensory therapy with
continuous monitoring until there is no difference in
measurements from baseline.
ASSESSMENT METHODS
Overview of assessments and variables derived
Each component of the intervention has a corresponding
outcome assessment or construct (table 1). These constructs
have been validated in the literature and performed in
our laboratories. Enhancement of sensory feedback has
as its outcome sensory processing; training of reach has
kinematics as an outcome; and the constraint-use itself
has the outcome of change in motor development.
Additionally, severity of CP will be classiﬁed at baseline.
The primary outcomes measures will include changes
in somatosensory processing as measured by the ERP
paradigm, improvements in reaching ability as measured
by kinematics of reach assessment, and improvements in
ﬁne motor development as measured by BSIDIII.
Classification of severity of CP
Rationale: Although asymmetry is distinguishable in very
young children with CP, tone characteristics are still
evolving (especially in preterm infants) making it
extremely difﬁcult to attribute classiﬁcations of spasticity,
diskynesia or ataxia.71 The degree of ﬁne motor
function impairment in hemiparetic or highly asymmet-
ric children with CP can be classiﬁed using standardised
systems such as the Bimanual Fine Motor Function
system (BFMF)107 or the Manual Abilities Classiﬁcation
system (MACS).108 The Surveillance of Cerebral Palsy in
Europe (SCPE) group recommendations for classiﬁca-
tion of CP were to use the BFMF as it ‘takes into
account possible asymmetry while MACS does not’.109
The BFMF also ﬁts well with the WHO ‘components of
health’ framework rather than the earlier models of
‘consequences of disease’, in which activity limitations
vary widely depending on the setting.107
Scoring: The study therapists will classify severity of CP
in every child using the BFMF at their baseline assess-
ment. The BFMF will be used to quantify baseline CP
severity and used in the analysis as described.
Somatosensory processing measurement by ERP
Recording: A high-density array of 128 electrodes
embedded in soft sponges (Geodesic Sensor Net, EGI,
Inc., Eugene, OR) will be used to record ERPs with a
sampling rate of 1000 Hz, ﬁlters set to 0.1–400 Hz
(ﬁgure 6).
All electrodes will be referred to Cz and re-referenced
ofﬂine to an average reference. Recording of brainwaves
will be controlled by Net Station (v. 4.3; EGI, Inc.,
Eugene, Oregon, USA). E-Prime (v. 2.0, PST, Inc.,
Pittsburgh, Pennsylvania, USA) software will control
stimulus delivery. Air puffs will be delivered using a
custom-made hand mold apparatus (Facility for Arts
Research, Florida State University, Tallahassee, Florida,
USA) with two ﬂexible nozzles, one positioned approxi-
mately 0.5′′ below the palm of hand secured in a
molded holder (puff condition), the other placed in
proximity but directed away (sham condition). The pres-
sure at the skin surface is 5 psi, or less than the pressure
of the smallest microﬁlament used to test for neuropa-
thies.54 For each hand, 60 puffs will be presented ran-
domly interspersed with 60 sham trials. To prevent
habituation, no more than two repetitions occur in a
row, and intertrial intervals vary randomly between 2000
and 2500 ms. The entire test session will last 8–10 min.
Table 1 Constructs and procedures
Construct Procedure(s)
Duration
(min) Variable
Severity of CP Bimanual Fine Motor
Function scale
5 Categories for fine motor impairment reflecting uni and
bimanual impairments
Somatosensory
processing
ERP to air puff 10 Average amplitudes in mV across predefined, published time
windows after stimulus onset, centroparietal and central
electrode clusters
Reaching ability Kinematics of reach 15 Sum number of movement units (smoothness), time from
presentation to first contact, time from first contact to grasp,
approach velocity, scores using a motion-tracking system
Fine motor
development
BSIDIII fine/gross
motor domains
15 Composite standardised scorer for bimanual function, scaled
scores for unimanual function, normed for CA
BSIDIII, Bayley Scales of Infant Development, 3rd Edition; CA, corrected age; CP, cerebral palsy; ERP, event-related potential.
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To facilitate cooperation, children will be offered an
age-appropriate video.
Kinematics of reach
Reaching is a developmentally relevant task representa-
tive of a skilled movement. In children with CP, reach is
impaired in its smoothness, range and accuracy. These
qualities can be quantiﬁed using kinematics or the study
of shape of movement path, velocity and acceleration.
Kinematics of reach are well studied and validated both
in TD and children with CP and allow an objective evalu-
ation of performance.
Procedure: The child seated in a supportive chair (with
trunk strap support if needed) will be asked to reach
unassisted for an object placed on a prepositioned
shelf at midline. The task will be repeated for three
trials in three conditions: reach with the less affected
arm (condition 1) and with the more affected arm
(condition 2), then reach for a larger object with both
arms (condition 3) to evaluate spontaneous and bilat-
eral reach.
Recording: We will use a motion analysis system (Vicon
Motion Systems Ltd, UK) including 4 infrared ‘Bonita 3’
cameras that track reﬂective markers at a rate of 240 Hz
with spatial precision at the 1 mm level to capture the
child’s movement in three-dimensional space. Markers
will be positioned bilaterally on the head of the second
metacarpal bone and on the object.110–113 Vicon Tracker
software will be used to determine the three-dimensional
position of the hand as it approaches each object, and to
construct segments, angles and moments using Matlab
software (The MathWorks Inc., Natick, Massachusetts,
USA).
Scoring: For each trial, approach velocity and move-
ment units (marked by changes in speed or position)
will be calculated. A single movement unit is deﬁned as
the portion of reach between one acceleration and
another.114 The sum composite of movement units in
one reach attempt is deﬁned as smoothness.115 116 The
motion tracking data will also be used to determine the
time from presentation to ﬁrst contact, time from ﬁrst
contact to grasp and approach velocity on the unilateral
task. In addition to these measures, in the bilateral task,
spontaneous use of the more versus less affected extre-
mity will be scored.
Bayley Scales of Infant and Toddler Development
(Bayley III) — 3rd Edition
Rationale: The Bayley III is the gold standard for the
evaluation of former NICU graduates, especially
preterm infants, and we have extensive experience using
it in the follow-up clinic.75 45 46 The motor scales
provide a developmental and functional assessment,
address unimanual as well as bimanual skills, are
normed against a large population and designed to be
adjusted for varying degrees of prematurity.
Procedure: The Bayley ﬁne and gross motor subscales
are currently administered in the follow-up clinic by
trained examiners who undergo yearly retraining to
maintain standards. The Bayley ﬁne motor items for
6–24 months (score range: 0–42) measure prehension,
motor planning, grasping patterns, and eye-hand coordi-
nation. The examiner is masked to intervention versus
control group membership and administers the ﬁne
motor subscale twice, repeating unilateral items for right
and left hands. Most (about 80%) of the Bayley ﬁne
motor items for infants aged 6–24 months require unila-
teral reach and grasp.
Scoring: In addition to standard testing, which gives a
composite score of the severity of motor delay or impair-
ment in young children and is a bimanual estimate, sep-
arate scores will be obtained to characterise the
difference between more and less affected extremity.
Using the method of Lowes et al,117 after standard
testing, unilateral items are repeated with the affected
extremity, using a soft sling constraint if needed (as in
the reach assessment). Scores for the unilateral items
are added to the bilateral items to produce a raw score
for each hand.117 All scores are corrected for GA.
Figure 6 Somatosensory ERP: geodesic ERP net and Air puff stimulus. ERP, event-related potential.
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Feasibility of assessments
We have conducted non-invasive ERP and neurobeha-
vioral studies in NICU infants and in older children (see
preliminary data) and can reliably test up to 10 children
5–12 years old using four separate assessments (total
100 minutes testing) in a single day. In the past 3 years,
our loss to follow-up at 6 months was less than 10%.
Missing data rates for all testing sessions were less than
5%. This high rate of successful data collection is due to
all children being tested on a single day to accommo-
date parent work-schedules and child care-schedules, as
well as a streamlined testing design during which chil-
dren rotate through research stations in scheduled time
blocks. Total assessment time in the current proposal
design is less than 1 h with a 5 min break between all sta-
tions, and appropriate play and snack areas in the
testing suite, making testing tolerable for very young
children and their parents.
ANALYSIS PLAN
Our ﬁrst aim is to demonstrate that CIMT improves the
sensory and motor function of an affected upper
extremity in young children with asymmetric CP. We will
use separate linear regression models to determine if, at
1-month and 7-month time points, ERP mean ampli-
tudes, reach precision, and Bayley motor scores differ by
intervention group in our CP participants. Each regres-
sion model will include an indicator variable for inter-
vention status and adjust for baseline CP severity to
increase the precision of the model. There are multiple
clinical end points in this study. We wish to answer separ-
ate questions and will report all negative as well as posi-
tive results, so no multiplicity corrections will be made
for the number of end points.118 The robust sandwich
estimator of the variance will be used to relax the con-
stant variance assumption in all regression models.
Secondary models will also adjust for lesion pattern on
neuroimaging118 and more affected side. Additionally,
secondary analyses will determine if duration of CIMT
intervention (Fitbit data) is associated with each
outcome. In the regression model, the indicator variable
for intervention status will be replaced with a continuous
function of the duration (average hours per day) of
CIMT wear. Duration will be ﬂexibly modelled using
restricted cubic splines to describe any non-straight-line
association and suggest a minimal duration needed to
see an effect of CIMT.
Sample power: For this aim, we are studying only the 36
participants with CP, randomised to receive CIMT imme-
diately (intervention group), and the 36 participants
with CP in the control group, not receiving CIMT
during the ﬁrst 7 months of study involvement. We will
use linear regression to estimate treatment effect while
adjusting for baseline CP severity as measured using the
BFMF. Including an adjustment variable in the model
will allow us to detect smaller effect sizes with the same
number of participants. The magnitude of the
improvement will depend on the percentage of variabil-
ity in each outcome that is explained by baseline CP
severity (R2Y,Z) as given in table 2.
If baseline CP severity and the outcome are uncorre-
lated, we will have 90% power to detect a 0.78 SD differ-
ence between intervention groups; if R2Y,Z=0.30, we will
have 90% power to detect a 0.54 SD difference between
intervention groups. Our hypothesis is that CIMT will
result in acute increases of absolute ERP mean ampli-
tudes (detection and attention to stimulus), and in even
greater effects by 3 months. We do not anticipate
1 month changes in bimanual motor function on the
Bayley III, but do expect to see improvements in standar-
dised scores for at 7 months as referenced to the
unaffected extremity. We anticipate 1 month improve-
ment in the more-affected extremity function on the
Bayley III and equal or greater effects at the 7-month
assessment. Improvements in reach kinematics and in
more-affected extremity performance on the Bayley III
should be tightly correlated to changes in ERP variables.
Our second aim is to characterise the association of
cortical sensory processing and motor function in the
upper extremities of young children with asymmetric
CP before CIMT
The primary goal of aim 2 is to quantify the differences
in sensory responses (mean amplitudes on ERP) and
motor function (reach kinematics, Bayley-scaled scores)
between (1) affected extremities of children with CP
and (2) those of upper extremities in age-matched chil-
dren without CP. A comparison between more-affected
and less-affected sides in children with CP will also allow
us to have a within-participants measure of asymmetry.
Increases in unimanual function should also result in
increasing bimanual function on the Bayley III.
The secondary goal of the analysis will correlate ERP
mean amplitudes of predeﬁned peaks with measures of
motor function in children with CP. We hypothesise that
improved cortical sensory processing will predict
increased unimanual and bimanual upper extremity
motor function.
Sample power: We are planning a study with 72 CP and
the set of 72 TD participants matched at the baseline
assessment. In a previous study, we found that the SD of
ERP amplitudes was 1.8 µV at P50, 3.6 µV at N140, and
3.2 µV at P200. We will be able to detect a true differ-
ence in mean amplitude between CP and TD partici-
pants of 0.98 µV (P50), 2.0 µV (N140), and 1.7 µV
(P200) with power 0.90 (α=0.05). In the pilot data, we
saw mean peak differences that were between 0.39 and
2.48 units between affected and less-affected extremity.
Therefore, we are using a very conservative estimate of
Table 2 Percentage of variability by baseline CP severity
R2y,z 0 0.05 0.10 0.20 0.30
Std Effect Size 0.78 0.74 0.70 0.62 0.54
Chorna O, et al. BMJ Open 2015;5:e010212. doi:10.1136/bmjopen-2015-010212 9
Open Access
difference for our calculation: the effect size of
between-TD-versus-CP differences is expected to be
greater than that assumed for the affected versus
less-affected variables in children with CP. For other out-
comes, we have 90% power to detect a 0.54 SD differ-
ence between CP and TD, a small difference given
published motor function differences >2 SD. For aim
2B, we will have 90% power to detect a correlation of
0.37 between ERP, Bayley, and reach kinematics in the
72 CP participants. ERPs in participants with CP should
show decreased detection and awareness of light touch
as measured by absolute mean amplitudes in affected
extremities versus less-affected and versus TD children.
Decreased cortical processing should in turn correlate
with increased smoothness of reach, decreased approach
velocity and higher Bayley III composite and affected
extremity scores. Based on sensorimotor principles of
learning, children with CP with worse sensory function
should have decreased performance on reach kine-
matics and Bayley III as compared to those with sensory
function closer to that of TD children.
The third aim is to characterise the change of sensory
and motor function of children with CP receiving CIMT
as referenced to TD children
Rationale: Published motor function trajectories in CP indi-
cate that gross motor function throughout childhood
improves but does not reach levels comparable to TD chil-
dren.119 The gains achieved and the maintenance of gains
are dependent on the severity of disease at baseline, with
more severely affected children having more limited trajec-
tories and even losing childhood gains into adulthood.
Upper extremity function is less well studied, but similar
patterns have been demonstrated in the more-affected
extremity.120 121 Children receiving standard clinical ther-
apies show few improvements over the course of 12
months,24 as measured by kinematics or neurobehavioral
measures. The function of the more-affected extremity
can decline until 18 years of age, even as the less-affected
extremity continues to improve. This disparate combi-
nation of trajectories of the more-affected and less-affected
extremities results in patterns of bimanual function that
do not reach TD levels.122
The main goal of the third aim is to use TD
referenced-measures of function in children with CP who
received CIMT to examine change from baseline to
6 months after intervention as correlated with CP severity
at start of intervention.
Another goal is to examine the association of CA at
CIMT on trajectories of sensory and motor function in
children with CP as referenced to TD children.
Sample power: Sample size estimates are typically based
on assuming a relevant effect size to detect with a given
power. However, for aim 3, the research goal is to show
that CP participants are becoming more similar to TD
participants over time by showing the standardised units
getting closer to zero. As discussed by others,123 in these
instances, the sample size can be justiﬁed in terms of the
margin of error (half the 95% CI width) of our estimate.
For the purposes of the power calculation, we assume
that the standardised units will have a variance of
approximately 1. With 72 CP participants, we will be able
to estimate the mean at study end with a margin of error
of 0.24 standardisation units. When testing for difference
by timing of CIMT intervention, the margin of error will
be no larger than 0.33 standardisation units; as in aim 2,
the margin of error will decrease as the correlation
between baseline and study-end-standardised units
increases. In contrast to ﬁndings in children with CP
described above, we hypothesise that as DD improves
after CIMT, we will observe increases in performance
metrics on all cortical and neurobehavioral assessments
in the more-affected extremity as well as in bimanual
function, as referenced to TD children. If the BFMF,
which includes ﬁve levels, does not provide sufﬁcient pre-
cision for modelling of impairment, we will use the com-
posite Bayley III motor score, acknowledging that it is
more a direct measure of ability rather than impairment.
Data management
Only the Principal Investigator and the research coord-
inator will have access to individually identiﬁable private
information about human participants.
A Data Safety Monitoring Committee (DSMC) will
include the PI, two additional physicians, and an inde-
pendent community occupational therapist. The DSMC
will meet every 6 months to discuss the project and will
receive enrolment, adverse events and compliance
reports. The DSMC will have access to interim results
and make the ﬁnal decision to terminate the trial.
Data and Safety reports: Safety reports will include any
problems with compliance, adverse events, withdrawals
from the study, reports and events submitted to the IRB.
Data reports will include enrolment in all groups and
timelines. Adverse events will be evaluated on a continu-
ous basis with review by the DSMC. After 36 CP patients
have been enrolled (halfway point) an interim analysis
of upper extremity function effects only will be per-
formed and provided to the DSMC. Because the inter-
vention has been shown to be beneﬁcial with no major
or lasting concerns and the wait-list controls will also
receive the intervention, a limited interim analysis will
not jeopardise the ﬁnal results.
Any data on medical information and behavioural
assessments will be directly collected into the Research
Electronic Data Capture (RedCap), relying on a thor-
ough study-speciﬁc data dictionary deﬁned in an itera-
tive self-documenting process by all members of the
research team with planning assistance from the RIC.
We hope to reﬁne the CIMT intervention for future
proposals and for clinical practice. Associations between
sensory function at baseline and improvements in
sensory processing could prove invaluable to the design
of further training tasks to maximise sensory feedback
during movement. Associations between severity of CP
and effectiveness of treatment may help decide which
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children will beneﬁt most from CIMT versus other stand-
ard therapies. Additionally, using quality improvement
techniques in single centres or collaboratives, the inter-
vention could be implemented in non-academic settings
such as rural areas or resource-poor countries, with the
same CIMT design but less resource-intensive end
points, such as questionnaires.
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